Overview
One of the few peptides on this list with credible controlled human data — for skin, applied topically. It occurs naturally in plasma, declining roughly 60% between age 20 and 60, which is the origin of its anti-aging framing.
Cosmetic IngredientEstablished cosmetic ingredient with human topical data. Injectable use is unapproved and unstudied.
| Regulatory status | Established cosmetic ingredient with human topical data. Injectable use is unapproved and unstudied. |
|---|---|
| Drug class | Naturally occurring copper-binding tripeptide |
| Route | Topical (well studied); injectable (not studied) |
| Half-life | Topical residence measured in hours; declines with age in plasma |
| Evidence rating |
3/5 Moderate
Evidence rating 3 out of 5: Moderate
Small or early-phase human trials, or good controlled topical human data. |
| Studied in | Multiple controlled topical trials in facial photoaging, wound healing, and hair growth; extensive fibroblast and gene-expression work. |
How it works
Chelates copper(II) and delivers it to cells, modulating expression of a broad set of genes involved in extracellular matrix remodelling. Stimulates collagen I, elastin, glycosaminoglycan and proteoglycan synthesis while modulating metalloproteinase activity, and has antioxidant and anti-inflammatory effects.
Evidence base
Rated 3 of 5 — Moderate. Small or early-phase human trials, or good controlled topical human data.
- Among the better-supported peptides for topical use.
- Systemic evidence is essentially absent — do not conflate the two.
Benefits & potential uses
Bars indicate how well each claim is supported: three = strong human evidence, two = moderate, one = preliminary or preclinical.
-
Improved skin firmness and wrinkle depth Moderate evidence
Controlled facial trials with copper-peptide creams showed measurable improvements in wrinkle depth, skin density and elasticity versus vehicle.
-
Wound healing acceleration Moderate evidence
Human and animal studies show faster closure and better-organised collagen deposition in wounds.
-
Collagen and elastin stimulation Moderate evidence
Robust fibroblast data showing upregulation of matrix synthesis.
-
Hair follicle effects Preliminary
Small studies suggest increased follicle size and hair density with topical application.
-
Antioxidant and anti-inflammatory activity Preliminary
Reduces oxidative damage markers in laboratory models.
Risks, cons & cautions
Bars indicate seriousness: three = serious or common, two = moderate, one = minor.
-
Injectable use has no evidence base Serious
The credible data is topical. Injecting copper peptides for systemic anti-aging has not been studied and introduces copper-load questions.
-
Copper accumulation concern Moderate evidence
Chronic high-dose systemic copper exposure carries hepatic and neurologic risk; contraindicated in Wilson disease.
-
Skin irritation and contact dermatitis Minor
Occurs in a minority of topical users, more often at higher concentrations.
-
Incompatibility with vitamin C and some acids Minor
Direct co-application can destabilise the complex; separate application times are advised.
-
Wide variation in product concentration Moderate evidence
Cosmetic products differ enormously in actual GHK-Cu content and formulation quality.
Who should avoid it
- Wilson disease or copper metabolism disorders (systemic use)
- Known copper allergy
- Broken or actively infected skin without medical advice
If used under medical supervision, monitor
- Topical use: none required
- Systemic use: not advised outside research
Commonly confused with
These mix-ups cause real harm — two products sold under one name, or two molecules whose effects run in opposite directions.
Same GHK tripeptide. GHK-Cu carries a copper ion and works partly by delivering copper; palmitoyl tripeptide-1 carries a fatty tail for penetration and delivers no copper.
Compare side by sideRegulatory & legal status
Lawful as a cosmetic ingredient. Injectable preparations are unapproved.
Infographic
Where to read further
We link to live literature searches rather than a frozen citation list, so you always see current results — including anything published after our last review.
- PubMed — all published literature on GHK-Cu
- PubMed — randomized controlled trials only
- ClinicalTrials.gov — registered human trials
Related peptides in Skin & Cosmetic
Terms used on this page
- Extracellular Matrix (ECM)
- The extracellular matrix is the network of collagens, proteoglycans and glycoproteins outside cells that bears mechanical load, stores growth factors, and signals back to the cells within it.
- Glycosaminoglycans (GAGs)
- Glycosaminoglycans are long unbranched sugar chains of repeating disaccharides that hold water in the dermal ground substance and, except for hyaluronan, are sulfated and attached to core proteins.
- Matrix Metalloproteinase (MMP)
- Matrix metalloproteinases are zinc-dependent enzymes that cut extracellular matrix proteins, and their balance against tissue inhibitors decides whether tissue remodels or degrades.
- Elastin
- Elastin is the insoluble crosslinked protein that gives skin its recoil, deposited during development on microfibril scaffolds and effectively not replaced in adult life.
- Wrinkle Depth Measurement (Profilometry)
- Profilometry quantifies skin surface topography, from a silicone replica or by direct optical scanning, yielding roughness parameters used as objective wrinkle endpoints in cosmetic trials.
- Fibroblast
- A fibroblast is the mesenchymal cell that produces and maintains connective tissue matrix, and which differentiates into a contractile myofibroblast during wound repair.
This page is educational information, not medical advice. It cannot account for your medical history, medications, or risk factors. Do not start, stop or change any treatment based on it. Speak to a qualified healthcare professional who knows your case.